Effect of romosozumab vs. alendronate on osteoporosis fracture risk

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Journal	Journal of Clinical Outcomes Management
Volume	25
Issue number	3
State	Published - Mar 2018
Externally published	Yes

ASJC Scopus subject areas

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{a241c78be1c84dd798dda57637160763,

title = "Effect of romosozumab vs. alendronate on osteoporosis fracture risk",

author = "Simona Frunza-Stefan and Whitlach, \{Hillary B.\}",

year = "2018",

month = mar,

language = "English (US)",

volume = "25",

journal = "Journal of Clinical Outcomes Management",

issn = "1079-6533",

publisher = "Frontline Medical Communications Inc.",

number = "3",

}

TY - JOUR

T1 - Effect of romosozumab vs. alendronate on osteoporosis fracture risk

AU - Frunza-Stefan, Simona

AU - Whitlach, Hillary B.

PY - 2018/3

Y1 - 2018/3

UR - https://www.scopus.com/pages/publications/85043497421

UR - https://www.scopus.com/pages/publications/85043497421#tab=citedBy

M3 - Comment/debate

AN - SCOPUS:85043497421

SN - 1079-6533

VL - 25

JO - Journal of Clinical Outcomes Management

JF - Journal of Clinical Outcomes Management

IS - 3

ER -